Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C15orf52 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | SERF1B | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | TNFRSF14 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
mRNA | ARHGEF9 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | SPATA12 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | LYSMD1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | RFC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | NAGPA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | RP5-874C20.8 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | TDG | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |